https://theconversation.com/lecanemab-experimental-drug-is-a-ray-of-hope-for-alzheimers-disease-196719
0
0
12/21/22 at 7:15pm
Organization
The Conversation Africa
An 18-month treatment with lecanemab slows functional and cognitive loss by 27 per cent in people with mild Alzheimer’s disease. But this is only the first step towards a real cure.
Create an account
or login to join the discussion